SEC Company Response from BioRestorative Therapies, Inc. (BRTX) (CIK 0001505497) (BRTX) — Oct 20, 2015
BioRestorative Therapies, Inc. (BRTX) (CIK 0001505497)
Date: Oct. 20, 2015 · CIK: 0001505497 · Accession: 0001021771-15-000060
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-204672
Letter
aegisacceleration.htm
AEGIS CAPITAL CORP.
810 Seventh Avenue
18th Floor
New York, NY 10019
October 19, 2015
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: BioRestorative Therapies, Inc. (the “Company”)
Registration Statement, as amended on Form S-1 (File No. 333-204672)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), Aegis Capital Corp., as underwriter, hereby joins in the request of the Company for the acceleration of the effective date of the above-referenced Registration Statement, so that it will become effective at 5:00 p.m., eastern daylight savings time, on Wednesday, October 21, 2015, or as soon thereafter as practicable.
We hereby authorize each of Lawrence G. Nusbaum, Esq., Andrew Russell, Esq. and Bryan S. Dixon, Esq. of Gusrae Kaplan Nusbaum PLLC, attorneys for the underwriter, to orally modify or withdraw this request for acceleration.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to be invited to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned, as underwriter, represents that it has and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature page to follow]
Very truly yours,
AEGIS CAPITAL CORP.
Show Raw Text
CORRESP
1
filename1.htm
aegisacceleration.htm
AEGIS CAPITAL CORP.
810 Seventh Avenue
18th Floor
New York, NY 10019
October 19, 2015
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
BioRestorative Therapies, Inc. (the “Company”)
Registration Statement, as amended on Form S-1 (File No. 333-204672)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), Aegis Capital Corp., as underwriter, hereby joins in the request of the Company for the acceleration of the effective date of the above-referenced Registration Statement, so that it will become effective at 5:00 p.m., eastern daylight savings time, on Wednesday, October 21, 2015, or as soon thereafter as practicable.
We hereby authorize each of Lawrence G. Nusbaum, Esq., Andrew Russell, Esq. and Bryan S. Dixon, Esq. of Gusrae Kaplan Nusbaum PLLC, attorneys for the underwriter, to orally modify or withdraw this request for acceleration.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to be invited to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned, as underwriter, represents that it has and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature page to follow]
Very truly yours,
AEGIS CAPITAL CORP.
By:
/s/ David Hentschel
Name: David Hentschel
Title: Compliance Officer
[Signature Page to Acceleration Request]